Ferroptosis: A New Promising Target for Lung Cancer Therapy
Author(s) -
Rui Xiong,
Ruyuan He,
Bohao Liu,
Wenyang Jiang,
Bo Wang,
Ning Li,
Qing Geng
Publication year - 2021
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2021/8457521
Subject(s) - pyroptosis , autophagy , carcinogenesis , lung cancer , cancer research , apoptosis , programmed cell death , gpx4 , cancer , biology , cell , cancer cell , medicine , microbiology and biotechnology , oxidative stress , pathology , biochemistry , genetics , catalase , glutathione peroxidase
Ferroptosis is a new type of regulatory cell death that differs from autophagy, apoptosis, necrosis, and pyroptosis; it is caused primarily by the accumulation of iron and lipid peroxides in the cell. Studies have shown that many classical signaling pathways and biological processes are involved in the process of ferroptosis. In recent years, investigations have revealed that ferroptosis plays a crucial role in the progression of tumors, especially lung cancer. In particular, inducing ferroptosis in cells can inhibit the growth of tumor cells, thereby reversing tumorigenesis. In this review, we summarize the characteristics of ferroptosis from its underlying basis and role in lung cancer and provide possible applications for it in lung cancer therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom